Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Lis RT"'
Autor:
Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA, Transdisciplinary Prostate Cancer Partnership ToPCaP, FIORENTINO, MICHELANGELO
BACKGROUND: In the United States, half of men with prostate cancer harbor the androgen-regulated gene fusion TMPRSS2:ERG. We hypothesized that men with TMPRSS2:ERG positive tumors are more responsive to androgen deprivation therapy (ADT). METHODS: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::957ae2bed8ef52d407961ad831654f9c
http://hdl.handle.net/11585/577878
http://hdl.handle.net/11585/577878
Autor:
Sam Peisch, Michelangelo Fiorentino, Kathryn L. Penney, Lorelei A. Mucci, Massimo Loda, Jennifer A. Sinnott, Jennifer R. Rider, Meir J. Stampfer, Rosina T. Lis, Svitlana Tyekucheva, Travis Gerke
Publikováno v:
Clinical Cancer Research. 23:81-87
Purpose: Gleason score strongly predicts prostate cancer mortality; however, scoring varies among pathologists, and many men are diagnosed with intermediate-risk Gleason score 7. We previously developed a 157-gene signature for Gleason score using a
Autor:
Svitlana Tyekucheva, Levi Waldron, Michelangelo Fiorentino, Rosina T. Lis, Lorelei A. Mucci, Michael J. Birrer, Edward C. Stack, Massimo Loda, Meir J. Stampfer, Wei Wei, Vinod Vathipadiekal, Giovanni Parmigiani, Neil E. Martin
Publikováno v:
The Journal of Molecular Diagnostics. 17:374-381
Archival formalin-fixed, paraffin-embedded (FFPE) tissue specimens represent a readily available but largely untapped resource for gene expression profiling-based biomarker discovery. Several technologies have been proposed to cope with the bias from
Autor:
Thomas U. Ahearn, Jennifer R. Rider, Kathryn M. Wilson, Stacey A. Kenfield, Bernard Rosner, Michelangelo Fiorentino, Edward Giovannucci, Rebecca E. Graff, Andreas Pettersson, Lorelei A. Mucci, Stephen P. Finn, Rosina T. Lis, Sarah C. Markt, Massimo Loda
Publikováno v:
Europe PubMed Central
BACKGROUND: There is limited evidence that supports etiologically distinct molecular subtypes of prostate cancer, the identification of which may improve prevention. Given their antioxidant properties, we hypothesized that lycopene and tomato sauce m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36690552aaad133ed4d7d89801a64982
http://hdl.handle.net/11585/577871
http://hdl.handle.net/11585/577871
Autor:
Lorelei A. Mucci, Whitney K. Hendrickson, Gregory L Judson, Edward C. Stack, Christopher S. Sweeney, Dyane Bailey, Andreas Pettersson, Meir J. Stampfer, Elizabeth Nuttall, Stephen P. Finn, Edward Giovannucci, Philip W. Kantoff, Neil E. Martin, Katja Fall, Rosina T. Lis, Michelangelo Fiorentino, Howard D. Sesso, Jennifer A. Sinnott, Lauren M. Kunz, Massimo Loda, Jennifer R. Rider, Richard Flavin, Christopher Fiore, Kathryn L. Penney
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 20(18)
Purpose: SPINK1 overexpression has been described in prostate cancer and is linked with poor prognosis in many cancers. The objective of this study was to characterize the association between SPINK1 overexpression and prostate cancer–specific survi
Autor:
Kathryn L. Penney, Michelangelo Fiorentino, Meir J. Stampfer, Stephen P. Finn, Neil E. Martin, Richard Flavin, Lorelei A. Mucci, Massimo Loda, Ladan Fazli, Michael Pollak, Jennifer A. Sinnott, Jing Ma, Tarek A. Bismar, Edward Giovannucci, Rosina T. Lis, Martin E. Gleave, Ke Zu
Background: Loss of PTEN has been shown to be associated with aggressive behavior of prostate cancer. It is less clear that loss of PTEN also increases the risk of cancer mortality. We investigated the association between PTEN expression and prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54ef07d887d39f4d4c207347891b63c
http://hdl.handle.net/11585/577881
http://hdl.handle.net/11585/577881
Autor:
Michelangelo Fiorentino, Edward Giovannucci, Michael Pollak, Allison Meisner, Richard Flavin, Philip W. Kantoff, Neil E. Martin, Rosina T. Lis, Jennifer R. Rider, Elizabeth Nuttall, Kathryn L. Penney, Massimo Loda, Edward C. Stack, Rebecca E. Graff, Andreas Pettersson, Stephen P. Finn, Meir J. Stampfer, Howard D. Sesso, Lorelei A. Mucci
Prostate cancer patients who are overweight have greater risk of disease recurrence and cancer-specific mortality (1,2). In the United States, 238590 men will be diagnosed with prostate cancer in 2013, and two-thirds of the adult male population is o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef690744617ff9e14bd533b131ddc6a
http://hdl.handle.net/11585/577902
http://hdl.handle.net/11585/577902
Autor:
Andreas Pettersson, Meir J. Stampfer, Michael J. Pitt, Howard D. Sesso, Edward Giovannucci, Jennifer R. Rider, Martin G. Sanda, Philip W. Kantoff, Azra H. Ligon, Rebecca E. Graff, Lorelei A. Mucci, Michelangelo Fiorentino, Catherine A. Suppan, Richard Flavin, Scott R. Bauer, Edward C. Stack, Massimo Loda, Kathryn L. Penney, Eric L. Ding, Neil E. Martin, Christopher Sweeney, Rosina T. Lis, Lauren Kunz
Background: Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):v-ets erythroblastosis virus E26 oncogene homolog (ERG) has prognostic value in prostate cancer is unclear. Methods: Among men with prostate cancer in the prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3315418a1382faf01631db54b46d3996
http://hdl.handle.net/11585/577835
http://hdl.handle.net/11585/577835
Autor:
Wilkinson S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Ku AT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Lis RT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., King IM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Low D; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Trostel SY; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Bright JR; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Terrigino NT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Baj A; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Fenimore JM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Li C; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Vo B; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Jansen CS; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Ye H; Department of Pathology and Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Whitlock NC; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Harmon SA; Molecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA., Carrabba NV; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Atway R; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Lake R; Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kissick HT; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Pinto PA; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, USA., Choyke PL; Molecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA., Turkbey B; Molecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA., Dahut WL; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA., Sowalsky AG; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Feb 11. Date of Electronic Publication: 2024 Feb 11.
Autor:
Stopsack KH; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Su XA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Vaselkiv JB; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Graff RE; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.; Division of Research, Kaiser Permanente Northern California, Oakland, California.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Ebot EM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Pettersson A; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Lis RT; Department of Pathology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fiorentino M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy., Loda M; Department of Pathology, Weill Cornell Medical College, New York, New York., Penney KL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Maryland., Lotan TL; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Mucci LA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2023 Jan 03; Vol. 21 (1), pp. 14-23.